Attached files
| file | filename |
|---|---|
| 10-Q/A - FORM 10-Q/A - Sonnet BioTherapeutics Holdings, Inc. | v330544_10qa.htm |
| EX-31.01 - EXHIBIT 31.01 - Sonnet BioTherapeutics Holdings, Inc. | v330544_ex31-01.htm |
| EX-31.02 - EXHIBIT 31.02 - Sonnet BioTherapeutics Holdings, Inc. | v330544_ex31-02.htm |
Exhibit 32.1
CHANTICLEER HOLDINGS, INC. FORM 10-Q/A FOR THE QUARTER ENDED JUNE 30, 2012
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Chanticleer Holdings, Inc. (the “Company”) on Form 10-Q/A for the period ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report), each of the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, and |
| 2. | The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| December 19, 2012 | /s/ Michael D. Pruitt | |
| Michael D. Pruitt | ||
| Chief Executive Officer | ||
| December 19, 2012 | /s/ Eric S. Lederer | |
| Eric S. Lederer | ||
| Chief Financial Officer | ||